Document Detail


Antioxidant potential of specific estrogens on lipid peroxidation.
MedLine Citation:
PMID:  8408459     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Coronary heart disease (CHD) is the leading cause of death in postmenopause. Estrogen administration in postmenopause lowers the risk of CHD by 50%. A variety of estrogen preparations are currently used in postmenopausal hormone replacement therapy. It is unknown, however, if structural differences in the estrogen molecule influence the cardioprotective effects of estrogens. In this communication we have shown that equine estrogens (especially equilin) exhibit higher antioxidant potency (as measured by fatty acids and sterols oxidation) when compared to estrone and estradiol-17 beta.
Authors:
M T Subbiah; B Kessel; M Agrawal; R Rajan; W Abplanalp; Z Rymaszewski
Related Documents :
1903699 - Proteolytic processing of thyroglobulin by extracts of thyroid lysosomes.
6318849 - Inhibition of lipogenesis by vasopressin and angiotensin ii in glycogen-depleted hepato...
19073199 - Role of 1alpha,25(oh)2 vitamin d3 on alpha-[1-(14)c]meaib accumulation in immature rat ...
4501579 - Proparathyroid hormone: identification of a biosynthetic precursor to parathyroid hormone.
3040139 - Hormone evolution studies: multiplication promoting and imprinting ("memory") effects o...
9543689 - Fatty acids inhibit adrenocorticotropin-induced adrenal steroidogenesis.
19299029 - Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-se...
18967909 - Spectrofluorimetric method for determination of aluminium with chromotropic acid and it...
15018069 - Decomposition of aqueous diphenyloxide by ozonolysis and by combined gamma-ray-ozone pr...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  77     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1993-11-12     Completed Date:  1993-11-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1095-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, University of Cincinnati College of Medicine, OH 45267-0540.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Line
Cholesterol / metabolism
Dose-Response Relationship, Drug
Equilin / pharmacology
Estradiol / pharmacology
Estrogens / pharmacology*
Estrone / pharmacology
Fatty Acids / metabolism
Humans
Lipid Peroxidation / drug effects*
Lipoproteins, LDL / metabolism
Macrophages / drug effects,  metabolism
Malondialdehyde / metabolism
Monocytes / drug effects,  metabolism
Oxidation-Reduction
Chemical
Reg. No./Substance:
0/Estrogens; 0/Fatty Acids; 0/Lipoproteins, LDL; 474-86-2/Equilin; 50-28-2/Estradiol; 53-16-7/Estrone; 542-78-9/Malondialdehyde; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
Next Document:  Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashi...